CTSL and COVID-19: The clinical data from this study indicated that human plasma CTSL activity and concentration were correlated with acute (in euglycemic participants under high-glucose clamp conditions) and chronic (in diabetic patients, both with and without COVID-19) hyperglycemia, respectively.